Dermatology - Other

Research output

Research output per year 1980 1992 1993 1995 1996 1997 1998 2001 2003 2006 2009 2011 2012 2014 2015 2017 2019 2024 2024

• 265 Article
• 44 Review article
• 39 Letter
• 26 Comment/debate
• 24 More
  • 14 Editorial
  • 9 Chapter
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2024

  A Case Series of TNF Inhibitor-Induced Psoriasis Successfully Treated With Upadacitinib

  Woodbury, M. J., Grant, C., Perez-Chada, L., LaChance, A. H. & Merola, J. F., Feb 1 2024, In: Journal of drugs in dermatology : JDD. 23, 2, p. e60-e63

  Research output: Contribution to journal › Article › peer-review

  • upadacitinib 100%
  • Tumor Necrosis Factor Inhibitors 61%
  • Janus Kinase Inhibitors 53%
  • Psoriasis 49%
  • Tumor Necrosis Factor-alpha 36%

• A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers

  Zundell, M. P., Merola, J. F. & Gottlieb, A. B., Feb 2024, In: Journal of Drugs in Dermatology. 23, 2, p. 105-109 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Hidradenitis Suppurativa 100%
  • Health Personnel 59%
  • Patient Care 53%
  • Communication 51%
  • Dermatology 17%

• Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasis

  Blauvelt, A., Rich, P., Sofen, H., Strober, B., Merola, J. F., Lebwohl, M., Morita, A., Szepietowski, J. C., Lambert, J., Hippeli, L., Colston, E., Balagula, E., Banerjee, S. & Thaçi, D., Apr 2024, In: Journal of the American Academy of Dermatology. 90, 4, p. 775-782 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • TYK2 Kinase 100%
  • Scalp 66%
  • Psoriasis 64%
  • apremilast 30%
  • Placebos 12%
  1 Scopus citations

• Editorial: Cutaneous lupus erythematosus landscape: pathophysiology, unmet needs, and related challenges in clinical practice. What is on the horizon?

  Merola, J. F., Nyberg, F., Franchimont, N., Barbey, C. & Werth, V. P., 2024, In: Frontiers in Medicine. 11, 1373552.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial

  Merola, J. F., Parish, L. C., Guenther, L., Lynde, C., Lacour, J. P., Staubach, P., Cheng, S., Paris, M., Picard, H., Deignan, C., Jardon, S., Chen, M. & Papp, K. A., Mar 2024, In: Journal of the American Academy of Dermatology. 90, 3, p. 485-493 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • apremilast 100%
  • Psoriasis 58%
  • Genitalia 54%
  • Placebos 40%
  • Safety 34%
  1 Scopus citations

• Expert consensus achieved on a working core outcome set for cutaneous lupus erythematosus research in survey following the 5th International Conference on Cutaneous Lupus Erythematosus (ICCLE)

  Zhang, A. J., Perez-Chada, L. M., Werth, V. P. & Merola, J. F., Feb 26 2024, In: Lupus Science and Medicine. 11, 1, e001165.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast]

  Merola, J. F. & Amin, A. Z., 2024, In: Clinical, Cosmetic and Investigational Dermatology. 17, p. 539-545 7 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Webcasts 100%
  • Psoriasis 61%
  • Social Change 6%
  • Skin 6%
  • Interleukins 6%

• Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation

  Medical Board of the National Psoriasis Foundation, Apr 2024, In: Journal of the American Academy of Dermatology. 90, 4, p. 727-730 4 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• Impact of oral, selective, allosteric tyrosine kinase 2 inhibitor, deucravacitinib, on psoriasis in patients with active psoriatic arthritis: results from a phase 2 trial

  Gottlieb, A. B., Armstrong, A. W., Merola, J. F., Napoli, A., Nowak, M., Banerjee, S., Lehman, T. & Mease, P. J., Mar 18 2024, In: SKIN: Journal of Cutaneous Medicine. 8, 2, p. S383

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

  Mease, P. J., Ogdie, A., Tesser, J., Shiff, N. J., Zhao, R. S., Chakravarty, S. D., Kelleman, M., Dodge, R., McLean, R. R., Broadwell, A., Kavanaugh, A. & Merola, J. F., 2024, (Accepted/In press) In: ACR Open Rheumatology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • guselkumab 100%
  • Psoriatic Arthritis 64%
  • Patient Reported Outcome Measures 59%
  • Registries 42%
  • ametantrone 30%

• Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation

  National Psoriasis Foundation Medical Board, Feb 2024, In: Journal of the American Academy of Dermatology. 90, 2, p. 408-410 3 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials

  Deodhar, A., Blauvelt, A., Lebwohl, M., Feely, M., Kronbergs, A., Eberhart, N., Zhu, D., Inman, E., Grace, E., Holzkaemper, T., Rahman, P., Marzo-Ortega, H., Papp, K. A., Merola, J. F., Gottlieb, A. B. & Schwartzman, S., Dec 2024, In: Arthritis Research and Therapy. 26, 1, 49.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • ixekizumab 100%
  • Psoriatic Arthritis 70%
  • Psoriasis 57%
  • Randomized Controlled Trials 39%
  • Safety 34%

• Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis A Systematic Review

  Pérez-Chada, L. M., Hopkins, Z. H., Balak, D. M. W., Rashid, S., Creadore, A., Chu, B., Villa, C., Woodbury, M. J., Armstrong, A. W., Strand, V., Gottlieb, A. B., Merola, J. F. & Barbieri, J. S., 2024, (Accepted/In press) In: JAMA Dermatology.

  Research output: Contribution to journal › Review article › peer-review

  • Patient Reported Outcome Measures 100%
  • Psoriasis 89%
  • Systematic Reviews 66%
  • Quality of Life 58%
  • Validation Studies 18%

• Rapid response of refractory subacute cutaneous lupus after single dose anifrolumab

  Gaffney, R. G. & Merola, J. F., Feb 2024, In: JAAD Case Reports. 44, p. 71-73 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel

  Burshtein, J., Shah, M., Zakria, D., Lockshin, B., Crowley, J., Merola, J. F., Gordon, K., Shahriari, M., Korman, N. J., Chovatiya, R., Kalb, R. & Lebwohl, M., Feb 2024, In: Dermatology and Therapy. 14, 2, p. 323-339 17 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • bimekizumab 100%
  • Psoriasis 45%
  • Consensus 43%
  • Safety 26%
  • Psoriatic Arthritis 18%

• Treatment of recalcitrant lupus erythematosus tumidus with deucravacitinib

  Zhang, A., Gaffney, R. G. & Merola, J. F., Mar 2024, In: JAAD Case Reports. 45, p. 110-112 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• TYK2: an emerging therapeutic target in rheumatic disease

  Morand, E., Merola, J. F., Tanaka, Y., Gladman, D. & Fleischmann, R., Apr 2024, In: Nature Reviews Rheumatology. 20, 4, p. 232-240 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • TYK2 Kinase 100%
  • Rheumatic Diseases 70%
  • Systemic Lupus Erythematosus 15%
  • Janus Kinase Inhibitors 11%
  • Janus Kinases 10%

• Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data

  Merola, J. F., Ertmer, B., Liang, H., Yue, X., Ofori, S. & Krueger, W., 2024, (Accepted/In press) In: Journal of the American Academy of Dermatology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Venous Thromboembolism 100%
  • Atopic Dermatitis 96%
  • Cohort Studies 63%
  • Psoriatic Arthritis 18%
  • Ankylosing Spondylitis 17%
  1 Scopus citations

• When handed lemons, beware of squeezing them

  Zhu, C. S., Trickett, J., O'Brien, J. & Cruz, P. D., Mar 2024, In: Contact Dermatitis. 90, 3, p. 327-328 2 p.

  Research output: Contribution to journal › Article › peer-review
• 2023

  International Dermatology Outcome Measures (IDEOM): Report From the 2022 Annual Meeting

  Lee, K., Woodbury, M. J., Zundell, M. P., Agüero, R., Yousif, J., Williams, S. C., Rosmarin, D., Silverberg, N., Thiboutot, D., Larocca, C., Shinohara, M. M., Mostaghimi, A., Ständer, S., Martorell, A., Jaleel, T., Torbeck, R. L., Siegel, D. M., Perez-Chada, L., Strand, V., Armstrong, A. W., & 2 othersMerola, J. F. & Gottlieb, A. B., Dec 2023, In: Journal of Drugs in Dermatology. 22, 12, p. 1153-1159 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Dermatology 100%
  • Health Care Outcome Assessment 64%
  • Nonprofit Organizations 24%
  • Hidradenitis Suppurativa 23%
  • Alopecia Areata 22%

• Sleep Problems in Patients With Psoriatic Arthritis: A Systematic Literature Review and Metaanalysis

  Grant, C., Woodbury, M., Skougaard, M., Boldsen, J. K., Ogdie, A., Klerman, E. B., Merola, J. F. & Perez-Chada, L. M., 2023, In: Journal of Rheumatology. 50, 12, p. 1594-1609 16 p.

  Research output: Contribution to journal › Review article › peer-review

  • Psoriatic Arthritis 100%
  • Sleep 64%
  • Systematic Reviews 60%
  • GLPG0634 11%
  • guselkumab 11%

• Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab

  Min, M. S., Mazori, D. R., Lee, M. S., Merola, J. F., AnnVleugels, R., Cobos, G. & LaChance, A. H., Dec 2023, In: Journal of Drugs in Dermatology. 22, 12, p. 1220-1222 3 p.

  Research output: Contribution to journal › Article › peer-review

  • dupilumab 100%
  • Hypertrophic Cicatrix 78%
  • Keloid 77%
  • Cicatrix 33%
  • Intralesional Injections 27%

• Teaching Patients to Teach Themselves (Not by Rote but) via Repeated Open Application Test

  Nowakowska, M. K., Sierro, T. & Cruz, P. D., Mar 1 2023, In: Dermatitis. 34, 2, p. 154-155 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review
• 2022

  A Burning Question for a Burning Mouth

  Catinis, A., Gao, W., Achtman, J. & Cruz, P. D., Mar 1 2022, In: Dermatitis. 33, 2, p. E10-E11

  Research output: Contribution to journal › Comment/debate › peer-review

• Discoidin domain receptor 2 regulates aberrant mesenchymal lineage cell fate and matrix organization

  Pagani, C. A., Bancroft, A. C., Tower, R. J., Livingston, N., Sun, Y., Hong, J. Y., Kent, R. N., Strong, A. L., Nunez, J. H., Medrano, J. M. R., Patel, N., Nanes, B. A., Dean, K. M., Li, Z., Ge, C., Baker, B. M., James, A. W., Weiss, S. J., Franceschi, R. T. & Levi, B., Dec 2022, In: Science Advances. 8, 51, eabq6152.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Discoidin Domain Receptor 2 100%
  • Heterotopic Ossification 74%
  • Extracellular Matrix 28%
  • Signal Transduction 17%
  • WW Domains 17%
  10 Scopus citations

• Increasing the field-of-view in oblique plane microscopy via optical tiling

  Chen, B., Chang, B. J., Zhou, F. Y., Daetwyler, S., Sapoznik, E., Nanes, B. A., Terrazas, I., Gihana, G. M., Castro, L. P., Chan, I. S., Conacci-Sorrel, M., Dean, K. M., Millett-Sikkin, A., York, A. G. & Fiolka, R., Nov 1 2022, In: Biomedical Optics Express. 13, 11, p. 5616-5627 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • field of view 100%
  • Microscopy 90%
  • microscopy 75%
  • high resolution 65%
  • Zebrafish 55%
  4 Scopus citations

• Iron Screening in Alopecia Areata Patients May Catch Hereditary Hemochromatosis Early

  Leung, B., Lindley, L., Cruz, P. D., Cole, S. & Ayoade, K. O., Oct 2022, In: Cutis. 110, 4, p. E30-E32

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Alopecia Areata 100%
  • Hemochromatosis 92%
  • Iron 60%
  • Iron Overload 14%
  • Skin Manifestations 14%

• Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer

  Hannan, R., Dohopolski, M. J., Pop, L. M., Mannala, S., Watumull, L., Mathews, D., Gao, A., Garant, A., Arriaga, Y. E., Bowman, I., Chung, J. S., Wang, J., Ariizumi, K., Ahn, C., Timmerman, R. & Courtney, K., Jun 2022, In: Biomedicines. 10, 6, 1419.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • sipuleucel-T 100%
  • Prostatic Neoplasms 48%
  • Radiation 46%
  • Radiotherapy 34%
  • Myeloid-Derived Suppressor Cells 32%
  3 Scopus citations

• Soluble DC-HIL/Gpnmb Modulates T-Lymphocyte Extravasation to Inflamed Skin

  Ramani, V., Chung, J. S., Ariizumi, K. & Cruz, P. D., May 2022, In: Journal of Investigative Dermatology. 142, 5, p. 1372-1380.e5

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hapten 100%
  • T-Lymphocytes 53%
  • Syndecan-4 52%
  • Skin 47%
  • Endothelial Cells 39%
  4 Scopus citations

• Training Physician‒Scientists for Careers in Investigative Dermatology

  Li, S., Yancey, K. B., Cruz, P. D. & Le, L. Q., Jan 2022, In: JID Innovations. 2, 1, 100061.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Dermatology 100%
  • Dermatologists 73%
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.) 65%
  • Medicine 24%
  13 Scopus citations
• 2021

  AllerGenie in a Bottle

  Shah, K. M. & Cruz, P. D., Nov 1 2021, In: Dermatitis. 32, 6, p. E121-E122

  Research output: Contribution to journal › Article › peer-review

• Dermatitis: Past, Present, Future

  Cruz, P. D. & Gaspari, A. A., 2021, In: Dermatitis. 32, 1, p. 3-4 2 p.

  Research output: Contribution to journal › Editorial › peer-review
• 2020

  Androgenetic alopecia in COVID-19: Compared to what?

  Nanes, B. A., Dec 2020, In: Journal of the American Academy of Dermatology. 83, 6, p. e451

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  9 Scopus citations

• Cutaneous polyarteritis nodosa with clinical features of pyoderma gangrenosum

  Pineider, J., Weon, J., West, L., Nanes, B., Vandergriff, T. & Mauskar, M. M., Dec 2020, In: JAAD Case Reports. 6, 12, p. 1291-1293 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• DC-HIL/GpNMB is a negative regulator of tumor response to immune checkpoint inhibitors

  Chung, J. S., Ramani, V., Kobayashi, M., Fattah, F., Popat, V., Zhang, S., Cruz, P. D., Gerber, D. E. & Ariizumi, K., Mar 15 2020, In: Clinical Cancer Research. 26, 6, p. 1449-1459 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • atezolizumab 100%
  • Myeloid-Derived Suppressor Cells 42%
  • Experimental Melanomas 39%
  • Neoplasms 35%
  • Non-Small Cell Lung Carcinoma 28%
  16 Scopus citations

• Ketotifen in Over-the-Counter Products Is a Contact Allergen

  Blackwell, W. & Cruz, P., Jul 1 2020, In: Dermatitis. 31, 4, p. E39-E40

  Research output: Contribution to journal › Letter › peer-review
  5 Scopus citations

• Opportunities for education during the COVID-19 pandemic

  Nguyen, K. D., Enos, T., Vandergriff, T., Vasquez, R., Cruz, P. D., Jacobe, H. T. & Mauskar, M. M., Jul 2020, In: JAAD International. 1, 1, p. 21-22 2 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access
  10 Scopus citations

• Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus

  Nanes, B. A., Zhu, J. L. & Chong, B. F., Jan 27 2020, In: Lupus Science and Medicine. 7, 1, p. AR e000364.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cutaneous Lupus Erythematosus 100%
  • Skin 37%
  • Health Care Outcome Assessment 9%
  • African Americans 7%
  • Cohort Studies 5%
  1 Scopus citations

• Verrucous pilar cysts infected with beta human papillomavirus

  Nanes, B. A., Laknezhad, S., Chamseddin, B., Doorbar, J., Mir, A., Hosler, G. A. & Wang, R. C., Apr 1 2020, In: Journal of Cutaneous Pathology. 47, 4, p. 381-386 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Epidermal Cyst 100%
  • Gammapapillomavirus 18%
  • keratohyalin 17%
  • Papilloma 12%
  • Papillomavirus Infections 12%
  4 Scopus citations
• 2019

  Addition of oral minipulse dexamethasone to narrowband ultraviolet B phototherapy and topical steroids helps arrest disease activity in patients with vitiligo

  Tovar-Garza, A., Hinojosa, J. A., Hynan, L. S. & Pandya, A. G., Jan 2019, In: British Journal of Dermatology. 180, 1, p. 193-194 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  18 Scopus citations

• A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis

  Kumarasinghe, S. P. W., Pandya, A., Chandran, V., Rodrigues, M., Dlova, N. C., Kang, H. Y., Ramam, M., Dayrit, J. F., Goh, B. K. & Parsad, D., Mar 2019, In: International Journal of Dermatology. 58, 3, p. 263-272 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Melanosis 100%
  • Lichen Planus 97%
  • Pigmentation 83%
  • Erythema 77%
  • Terminology 74%
  55 Scopus citations

• A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo

  McKesey, J. & Pandya, A. G., Aug 2019, In: Journal of the American Academy of Dermatology. 81, 2, p. 646-648 3 p.

  Research output: Contribution to journal › Article › peer-review
  33 Scopus citations

• A Subtle Historical Clue Unlocks a Contact Puzzle

  DeBord, L., Enos, T. & Cruz, P., Jan 1 2019, In: Dermatitis. 30, 1, p. 77 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  2 Scopus citations

• Blocking monocytic myeloid-derived suppressor cell function via anti-DC-HIL/GpNMB antibody restores the in vitro integrity of T cells from cancer patients

  Kobayashi, M., Chung, J. S., Beg, M., Arriaga, Y., Verma, U., Courtney, K., Mansour, J., Haley, B., Khan, S., Horiuchi, Y., Ramani, V., Harker, D., Gopal, P., Araghizadeh, F., Cruz, P. D. & Ariizumi, K., Jan 15 2019, In: Clinical Cancer Research. 25, 2, p. 828-838 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myeloid-Derived Suppressor Cells 100%
  • T-Lymphocytes 46%
  • Antibodies 41%
  • atezolizumab 39%
  • In Vitro Techniques 32%
  40 Scopus citations

• Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs)

  Ezzedine, K., Ahmed, M., Tovar-Garza, A., Hajj, C., Whitton, M., Pandya, A., Altalhab, S., Seneschal, J., Harris, J. & Taieb, C., Nov 2019, In: Journal of the American Academy of Dermatology. 81, 5, p. 1107-1114 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Vitiligo 100%
  • Skin 43%
  • France 5%
  • Cross-Sectional Studies 3%
  16 Scopus citations

• Disorders of Hypopigmentation

  Dina, Y., McKesey, J. & Pandya, A. G., Mar 2019, In: Journal of Drugs in Dermatology. 18, 3, p. S115-S116

  Research output: Contribution to journal › Article › peer-review

  • Hypopigmentation 100%
  • Vitiligo 45%
  • tofacitinib 18%
  • INCB018424 18%
  • Janus Kinase Inhibitors 16%
  4 Scopus citations

• Diversity is Excellence: Initiatives in the Society for Investigative Dermatology to Broaden Participation

  Horsley, V., Glass, D., Minnillo, R., Gallo, R., Cruz, P. & Ward, N. L., Oct 2019, In: Journal of Investigative Dermatology. 139, 10, p. 2217-2219 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• Expansion of Myeloid-Derived Suppressor Cells in the Peripheral Blood and Lesional Skin of Cutaneous Lupus Patients

  Florez-Pollack, S., Tseng, L. C., Kobayashi, M., Hosler, G. A., Ariizumi, K. & Chong, B., Feb 2019, In: Journal of Investigative Dermatology. 139, 2, p. 478-481 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  14 Scopus citations

• International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation

  Eleftheriadou, V., Hamzavi, I., Pandya, A. G., Grimes, P., Harris, J. E., Huggins, R. H., Lim, H. W., Elbuluk, N., Bhatia, B., Tovar-Garza, A., Nahhas, A. F., Braunberger, T. & Ezzedine, K., Mar 2019, In: British Journal of Dermatology. 180, 3, p. 574-579 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Vitiligo 100%
  • Education 49%
  • Consensus 18%
  • Pigmentation 11%
  • Caregivers 8%
  34 Scopus citations

• Noncultured epidermal suspension grafting using suction blisters as donor tissue for vitiligo

  Tovar-Garza, A., Hinojosa, J. A., Hynan, L. S. & Pandya, A. G., Apr 2019, In: Journal of the American Academy of Dermatology. 80, 4, p. 1152-1154 3 p.

  Research output: Contribution to journal › Article › peer-review
  7 Scopus citations